Accounts Submission

DB PHARMA CONSULTING LIMITED - Company Information

Company Accounts and Tax Online 14381610 Board of Directors 28.9.22 30.9.23 30.9.23 No description of principal activity false iso4217:GBP xbrli:pure 14381610 2023-09-30 14381610 2022-09-28 2023-09-30 14381610 countries:EnglandWales 2022-09-28 2023-09-30 14381610 curr:PoundSterling 2022-09-28 2023-09-30 14381610 uk-bus:PrivateLimitedCompanyLtd 2022-09-28 2023-09-30 14381610 uk-bus:Micro-entities 2022-09-28 2023-09-30 14381610 uk-bus:AuditExempt-NoAccountantsReport 2022-09-28 2023-09-30 14381610 uk-bus:FullAccounts 2022-09-28 2023-09-30 14381610 uk-bus:RegisteredOffice 2022-09-28 2023-09-30 14381610 uk-bus:Director1 2022-09-28 2023-09-30 14381610 uk-bus:Director1 2022-09-28 14381610 uk-bus:Director1 2023-09-30 14381610 core:AfterOneYear 2023-09-30 14381610 core:WithinOneYear 2023-09-30 14381610 core:WithinOneYear 2022-09-28 2023-09-30 14381610 core:AfterOneYear 2023-09-30 14381610 core:AfterOneYear 2022-09-28 2023-09-30 14381610 core:ShareCapital 2023-09-30 14381610 core:RevaluationReserve 2023-09-30 14381610 core:RetainedEarningsAccumulatedLosses 2023-09-30 14381610 1 2022-09-28 2023-09-30

Company Registration Number:
14381610 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2023

Period of accounts

Start date: 28 September 2022

End date: 30 September 2023

Contents of the Financial Statements

for the Period Ended 30 September 2023


Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

Profit and Loss Account

for the Period Ended 30 September 2023

	2023 £
Turnover	16,000
Income from coronavirus (COVID-19) business support grants	0
Other Income	0
Cost of Materials	( 0 )
Staff Costs	( 11,000 )
Depreciation and Writeoffs	( 395 )
Other charges	( 363 )
Tax on Profit	( 807 )
Profit or (Loss) for Period	3,435

Balance sheet

As at 30 September 2023

	2023 £
Called up share capital not paid:	0
Fixed Assets:	0
Current assets:	3,435
Prepayments and accrued income:	0
Creditors: amounts falling due within one year:	( 0 )
Net current assets (liabilities):	3,435
Total assets less current liabilities:	3,435
Creditors: amounts falling due after more than one year:	( 0 )
Accruals and deferred income:	( 0 )
Total net assets (liabilities):	3,435
Capital and reserves:	3,435

Balance sheet continued

For the year ending 30 September 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 6 January 2024
And Signed On Behalf Of The Board By:

Name: Daniel Bell
Status: Director

The notes form part of these financial statements

Footnotes to the Financial Statements

for the Period Ended 30 September 2023

1. Employee Information

Average number of employees: 1

Footnotes to the Financial Statements

for the Period Ended 30 September 2023

2. Off balance sheet disclosure

No



Registered office:		20 Bracken Ridge Morpeth GBR NE61 3SY


Company Registration Number:		14381610 (England and Wales)

Accounts Submission